Annual EBITDA
-$67.95M$32.80M-93.29%
Summary
- Current Value
- As of today, MBX annual EBITDA is -$67.95M, down -93.29% on
- Historical Performance
- MBX annual EBITDA is down -164.35% over the past 3 years, and down -164.35% over the past 5 years
- All-Time High Comparison
- MBX annual EBITDA is currently -164.35% below its historical high of -$25.71M set on
- 3-Year Low Comparison
- MBX annual EBITDA is at its 3-year low
- Sector Comparison
- MBX annual EBITDA is higher than 23.16% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$67.95M | -93.3% | -164.3% | -164.3% | -164.3% | |
| Quarterly EBITDA | -$23.83M | -22.1% | -276.4% | -276.4% | -276.4% | |
| TTM EBITDA | -$90.54M | -52.6% | -1330.3% | -1330.3% | -1330.3% | |
| Price | $30.72 | +111.7% | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$1.85 | -89.9% | -136.6% | -136.6% | -136.6% | |
| -$68.19M | -93.1% | -164.7% | -164.7% | -164.7% | ||
| Annual Net Income | -$61.92M | -90.2% | -136.9% | -136.9% | -136.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$25.71M | N/A | -164.3% |
| 5Y | -$25.71M | -164.3% | |
| All | -$25.71M | -164.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$67.95M | at low | |
| 5Y | -$67.95M | at low | |
| All | -$67.95M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$67.95M | -93.3% | |
| -$35.15M | -36.8% |
| Year | Value | Change |
|---|---|---|
| -$25.71M | - |
FAQ
What is the current annual EBITDA of MBX?
As of today, MBX annual EBITDA is -$67.95M
What is 1-year change in MBX annual EBITDA?
MBX annual EBITDA is down -93.29% year-over-year
What is 3-year change in MBX annual EBITDA?
MBX annual EBITDA is down -164.35% over the past 3 years
How far is MBX annual EBITDA from its all-time high?
MBX annual EBITDA is currently -164.35% below its historical high of -$25.71M set on December 1, 2022
How does MBX annual EBITDA rank versus sector peers?
MBX annual EBITDA is higher than 23.16% of companies in Healthcare sector
When is MBX next annual earnings release?
The next annual earnings release for MBX is on
Quarterly EBITDA
-$23.83M$2.12M-9.77%
Summary
- Current Value
- As of today, MBX quarterly EBITDA is -$23.83M, down -9.77% on
- Historical Performance
- MBX quarterly EBITDA is down -22.11% year-over-year, and down -276.40% over the past 3 years
- All-Time High Comparison
- MBX quarterly EBITDA is currently -276.40% below its historical high of -$6.33M set on
- 3-Year Low Comparison
- MBX quarterly EBITDA is +9.93% above its 3-year low of -$26.45M reached on
- Sector Comparison
- MBX quarterly EBITDA is higher than 17.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$23.83M | -9.8% | -22.1% | -276.4% | -276.4% | |
| Annual EBITDA | -$67.95M | – | -93.3% | -164.3% | -164.3% | |
| TTM EBITDA | -$90.54M | -5.0% | -52.6% | -1330.3% | -1330.3% | |
| Price | $30.72 | +93.7% | +111.7% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$0.63 | -8.9% | -16.3% | -254.7% | -254.7% | |
| -$23.93M | -9.7% | -22.0% | -275.8% | -275.8% | ||
| Quarterly Net Income | -$21.62M | -11.4% | -19.2% | -263.4% | -263.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$18.55M | N/A | -28.4% |
| 3Y | -$6.33M | -276.4% | |
| 5Y | -$6.33M | -276.4% | |
| All | -$6.33M | -276.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$26.45M | +9.9% | |
| 3Y | -$26.45M | +9.9% | |
| 5Y | -$26.45M | +9.9% | |
| All | -$26.45M | +9.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MBX?
As of today, MBX quarterly EBITDA is -$23.83M
What is MBX quarterly EBITDA most recent change?
MBX quarterly EBITDA was down -9.77% on September 30, 2025
What is 1-year change in MBX quarterly EBITDA?
MBX quarterly EBITDA is down -22.11% year-over-year
How far is MBX quarterly EBITDA from its all-time high?
MBX quarterly EBITDA is currently -276.40% below its historical high of -$6.33M set on March 1, 2023
How does MBX quarterly EBITDA rank versus sector peers?
MBX quarterly EBITDA is higher than 17.80% of companies in Healthcare sector
When is MBX next earnings release?
The next earnings release for MBX is on
TTM EBITDA
-$90.54M$4.31M-5.00%
Summary
- Current Value
- As of today, MBX TTM EBITDA is -$90.54M, down -5.00% on
- Historical Performance
- MBX TTM EBITDA is down -52.61% year-over-year, and down -1330.25% over the past 3 years
- All-Time High Comparison
- MBX TTM EBITDA is currently -1330.25% below its historical high of -$6.33M set on
- 3-Year Low Comparison
- MBX TTM EBITDA is at its 3-year low
- Sector Comparison
- MBX TTM EBITDA is higher than 18.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$90.54M | -5.0% | -52.6% | -1330.3% | -1330.3% | |
| Annual EBITDA | -$67.95M | – | -93.3% | -164.3% | -164.3% | |
| Quarterly EBITDA | -$23.83M | -9.8% | -22.1% | -276.4% | -276.4% | |
| Price | $30.72 | +93.7% | +111.7% | – | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$2.39 | -3.8% | -44.8% | -1243.2% | -1243.2% | |
| -$90.87M | -5.0% | -52.5% | -1327.2% | -1327.2% | ||
| TTM Net Income | -$80.50M | -4.5% | -45.9% | -1253.1% | -1253.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$67.93M | N/A | -33.3% |
| 3Y | -$6.33M | -1330.3% | |
| 5Y | -$6.33M | -1330.3% | |
| All | -$6.33M | -1330.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$90.54M | at low | |
| 3Y | -$90.54M | at low | |
| 5Y | -$90.54M | at low | |
| All | -$90.54M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MBX?
As of today, MBX TTM EBITDA is -$90.54M
What is MBX TTM EBITDA most recent change?
MBX TTM EBITDA was down -5.00% on September 30, 2025
What is 1-year change in MBX TTM EBITDA?
MBX TTM EBITDA is down -52.61% year-over-year
How far is MBX TTM EBITDA from its all-time high?
MBX TTM EBITDA is currently -1330.25% below its historical high of -$6.33M set on March 1, 2023
How does MBX TTM EBITDA rank versus sector peers?
MBX TTM EBITDA is higher than 18.61% of companies in Healthcare sector
When is MBX next earnings release?
The next earnings release for MBX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- MBX Official Website mbxbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1776111/000119312525268148/0001193125-25-268148-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776111/000095017025039838/0000950170-25-039838-index.htm
- MBX Profile on Yahoo Finance finance.yahoo.com/quote/MBX
- MBX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mbx